Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty
This retrospective study evaluated the safety and efficacy of SURGICEL® Powder–Absorbable Hemostatic Powder (SP) made from oxidized regenerated cellulose (ORC) in total knee arthroplasty (TKA). Ninety-one patients who underwent TKA at Peking University Third Hospital between January 2024 and July 20...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-12-01
|
| Series: | Clinical and Applied Thrombosis/Hemostasis |
| Online Access: | https://doi.org/10.1177/10760296241306749 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850099708515581952 |
|---|---|
| author | Xinguang Wang MD Zhencan Han MD Guowei Zhang MD Shantao Zhang MD Zijian Li MD Hua Tian MD |
| author_facet | Xinguang Wang MD Zhencan Han MD Guowei Zhang MD Shantao Zhang MD Zijian Li MD Hua Tian MD |
| author_sort | Xinguang Wang MD |
| collection | DOAJ |
| description | This retrospective study evaluated the safety and efficacy of SURGICEL® Powder–Absorbable Hemostatic Powder (SP) made from oxidized regenerated cellulose (ORC) in total knee arthroplasty (TKA). Ninety-one patients who underwent TKA at Peking University Third Hospital between January 2024 and July 2024 were retrospectively analyzed. Hemostatic effectiveness was evaluated by comparing perioperative blood loss, hemoglobin (Hb) levels, hematocrit (HCT), and transfusion rates. Clinical safety was assessed by comparing complication rates, operation time, visual analog scale (VAS) scores, and postoperative fever. Finally, 85 patients were included: 43 in the SP group (using SP) and 42 in the control group (not using SP). There were no significant differences in age, sex, height, weight, preoperative HCT, or Hb levels. The volume of perioperative blood loss within 3 days in the SP group was reduced by approximately 154 ml compared with that in the control group. The Hb and HCT levels in the SP group were higher on the first, second, and third days after surgery, and there were significant differences between the two groups in terms of repeated measurements of HCT and Hb levels within 3 days postoperatively. There were no statistically significant differences in the operation time, postoperative VAS scores, complications, transfusion rates, or postoperative fever. In conclusion, this study confirmed that SP can significantly reduce perioperative blood loss in TKA without negatively affecting clinical outcomes. |
| format | Article |
| id | doaj-art-73a946c2055b491daebd74a563e2b357 |
| institution | DOAJ |
| issn | 1938-2723 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Clinical and Applied Thrombosis/Hemostasis |
| spelling | doaj-art-73a946c2055b491daebd74a563e2b3572025-08-20T02:40:26ZengSAGE PublishingClinical and Applied Thrombosis/Hemostasis1938-27232024-12-013010.1177/10760296241306749Safety and Efficacy of a Novel Hemostatic Powder in Total Knee ArthroplastyXinguang Wang MD0Zhencan Han MD1Guowei Zhang MD2Shantao Zhang MD3Zijian Li MD4Hua Tian MD5 Department of Orthopedics, , Beijing, China Department of Orthopedics, , Beijing, China Department of Orthopedics, , Beijing, China Department of Orthopedics, Muping District Traditional Chinese Medicine Hospital, Yantai City, China Department of Orthopedics, , Beijing, China Department of Orthopedics, , Beijing, ChinaThis retrospective study evaluated the safety and efficacy of SURGICEL® Powder–Absorbable Hemostatic Powder (SP) made from oxidized regenerated cellulose (ORC) in total knee arthroplasty (TKA). Ninety-one patients who underwent TKA at Peking University Third Hospital between January 2024 and July 2024 were retrospectively analyzed. Hemostatic effectiveness was evaluated by comparing perioperative blood loss, hemoglobin (Hb) levels, hematocrit (HCT), and transfusion rates. Clinical safety was assessed by comparing complication rates, operation time, visual analog scale (VAS) scores, and postoperative fever. Finally, 85 patients were included: 43 in the SP group (using SP) and 42 in the control group (not using SP). There were no significant differences in age, sex, height, weight, preoperative HCT, or Hb levels. The volume of perioperative blood loss within 3 days in the SP group was reduced by approximately 154 ml compared with that in the control group. The Hb and HCT levels in the SP group were higher on the first, second, and third days after surgery, and there were significant differences between the two groups in terms of repeated measurements of HCT and Hb levels within 3 days postoperatively. There were no statistically significant differences in the operation time, postoperative VAS scores, complications, transfusion rates, or postoperative fever. In conclusion, this study confirmed that SP can significantly reduce perioperative blood loss in TKA without negatively affecting clinical outcomes.https://doi.org/10.1177/10760296241306749 |
| spellingShingle | Xinguang Wang MD Zhencan Han MD Guowei Zhang MD Shantao Zhang MD Zijian Li MD Hua Tian MD Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty Clinical and Applied Thrombosis/Hemostasis |
| title | Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty |
| title_full | Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty |
| title_fullStr | Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty |
| title_full_unstemmed | Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty |
| title_short | Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty |
| title_sort | safety and efficacy of a novel hemostatic powder in total knee arthroplasty |
| url | https://doi.org/10.1177/10760296241306749 |
| work_keys_str_mv | AT xinguangwangmd safetyandefficacyofanovelhemostaticpowderintotalkneearthroplasty AT zhencanhanmd safetyandefficacyofanovelhemostaticpowderintotalkneearthroplasty AT guoweizhangmd safetyandefficacyofanovelhemostaticpowderintotalkneearthroplasty AT shantaozhangmd safetyandefficacyofanovelhemostaticpowderintotalkneearthroplasty AT zijianlimd safetyandefficacyofanovelhemostaticpowderintotalkneearthroplasty AT huatianmd safetyandefficacyofanovelhemostaticpowderintotalkneearthroplasty |